InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | 2026-04-20 | Doyle John Brendan | Chief Financial Officer | Purchase | 10.0K | $1.13 | $11K | 627.5K | View ↗ | |
| 2026-04-16 | 2026-04-20 | Ricciardi Lisa | Director & CEO & President | Purchase | 9,175 | $1.10 | $10K | 1.72M | View ↗ |
No annual data found.
Cognition Therapeutics GAAP EPS of -$0.05 beats by $0.02
Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update
NanoViricides to Participate at D. Boral Capital Global Conference in NYC
NanoViricides’ Measles Treatment Granted Orphan Drug Designation by FDA